New

Neuroscience Antibodies And Assays Market

2021

Neuroscience Antibodies And Assays Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product ( Consumables, Instruments ); Technology ( Molecular Diagnostics, Clinical Chemistry, Immunoassays or Immunochemistry, Others ); Application ( In Vitro Diagnostics, Research, Drug Discovery ); End User ( Hospitals and Diagnostics Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies. )

| Report Code: TIPBT00002234 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Market Insights

Neuroscience Antibodies And Assays Market 2028 By Product, Technology, Application, End User | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW

Neuroscience involves the study of nervous system, where the research is completely relies on assays and antibodies. These antibodies and assays are specific that helps to identify and examine reactions on the cellular, biochemical and molecular level. Antibody-based approaches are used for the localization, isolation and characterization of targeted proteins that majorly used in the cellular and molecular neuroscience. On the other hand, the use of assays provide an efficient, valuable solution for determination of critical targets that are involved in synaptic signaling, neural development and neurodegeneration. The market is a perfect competition market with the presence of numerous market players and buyers. The market players are competing based on price, product innovation, and quality.

MARKET SCOPE

The "Global Neuroscience Antibodies & Assays Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of the neuroscience antibodies & assays market with detailed market segmentation by product, technology, application, end user, and geography. The report provides key statistics on the market status of the leading neuroscience antibodies & assays market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  • Based on product, the market is segmented as consumables and instruments.
  • On the basis of technology, the global neuroscience antibodies & assays market is segmented into molecular diagnostics, clinical chemistry, immunoassays/immunochemistry and others.
  • Based on application, the market is segmented as in vitro diagnostics, research and drug discovery.
  • Based on end user, the market is segmented as hospitals & diagnostics centers, academic & research institutes and pharmaceutical & biotechnology companies.

MARKET DYNAMICS

Drivers

  • Increasing incidence of neurological disorders.
  • Growing pharmaceutical & biotechnology industries and
  • Increasing investments in neuroscience research.

Restraints

  • Quality and Cost Concerns Over the Production of Antibodies

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The neuroscience antibodies & assays market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the neuroscience antibodies & assays market in these regions.

IMPACT OF COVID-19 ON NEUROSCIENCE ANTIBODIES & ASSAYS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19.

MARKET PLAYERS

The report covers key developments in the neuroscience antibodies & assays market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from neuroscience antibodies & assays market are anticipated to lucrative growth opportunities in the future with the rising demand for neuroscience antibodies & assays in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the neuroscience antibodies & assays market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Siemens
  • GenScript
  • Cell Signaling Technology, Inc.
  • Santa Cruz Biotechnology, Inc.
  • BioLegend, Inc.
  • Abcam plc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Neuroscience Antibodies And Assays Market - By Product
1.3.2 Neuroscience Antibodies And Assays Market - By Technology
1.3.3 Neuroscience Antibodies And Assays Market - By Application
1.3.4 Neuroscience Antibodies And Assays Market - By End User
1.3.5 Neuroscience Antibodies And Assays Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET - GLOBAL MARKET ANALYSIS
6.1. NEUROSCIENCE ANTIBODIES AND ASSAYS - GLOBAL MARKET OVERVIEW
6.2. NEUROSCIENCE ANTIBODIES AND ASSAYS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CONSUMABLES
7.3.1. Overview
7.3.2. Consumables Market Forecast and Analysis
7.3.3. Antibodies Market
7.3.3.1. Overview
7.3.3.2. Antibodies Market Forecast and Analysis
7.3.4. Reagents Market
7.3.4.1. Overview
7.3.4.2. Reagents Market Forecast and Analysis
7.3.5. Assays Kits Market
7.3.5.1. Overview
7.3.5.2. Assays Kits Market Forecast and Analysis
7.4. INSTRUMENTS
7.4.1. Overview
7.4.2. Instruments Market Forecast and Analysis
7.4.3. Microplate Readers Market
7.4.3.1. Overview
7.4.3.2. Microplate Readers Market Forecast and Analysis
7.4.4. Immunoassay Analyzers Market
7.4.4.1. Overview
7.4.4.2. Immunoassay Analyzers Market Forecast and Analysis
7.4.5. Others. Market
7.4.5.1. Overview
7.4.5.2. Others. Market Forecast and Analysis
8. NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. MOLECULAR DIAGNOSTICS
8.3.1. Overview
8.3.2. Molecular Diagnostics Market Forecast and Analysis
8.4. CLINICAL CHEMISTRY
8.4.1. Overview
8.4.2. Clinical Chemistry Market Forecast and Analysis
8.5. IMMUNOASSAYS OR IMMUNOCHEMISTRY
8.5.1. Overview
8.5.2. Immunoassays or Immunochemistry Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. IN VITRO DIAGNOSTICS
9.3.1. Overview
9.3.2. In Vitro Diagnostics Market Forecast and Analysis
9.4. RESEARCH
9.4.1. Overview
9.4.2. Research Market Forecast and Analysis
9.5. DRUG DISCOVERY
9.5.1. Overview
9.5.2. Drug Discovery Market Forecast and Analysis
10. NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS AND DIAGNOSTICS CENTERS
10.3.1. Overview
10.3.2. Hospitals and Diagnostics Centers Market Forecast and Analysis
10.4. ACADEMIC AND RESEARCH INSTITUTES
10.4.1. Overview
10.4.2. Academic and Research Institutes Market Forecast and Analysis
10.5. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES.
10.5.1. Overview
10.5.2. Pharmaceutical and Biotechnology Companies. Market Forecast and Analysis
11. NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Neuroscience Antibodies And Assays Market Overview
11.1.2 North America Neuroscience Antibodies And Assays Market Forecasts and Analysis
11.1.3 North America Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Product
11.1.4 North America Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Technology
11.1.5 North America Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Application
11.1.6 North America Neuroscience Antibodies And Assays Market Forecasts and Analysis - By End User
11.1.7 North America Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Countries
11.1.7.1 United States Neuroscience Antibodies And Assays Market
11.1.7.1.1 United States Neuroscience Antibodies And Assays Market by Product
11.1.7.1.2 United States Neuroscience Antibodies And Assays Market by Technology
11.1.7.1.3 United States Neuroscience Antibodies And Assays Market by Application
11.1.7.1.4 United States Neuroscience Antibodies And Assays Market by End User
11.1.7.2 Canada Neuroscience Antibodies And Assays Market
11.1.7.2.1 Canada Neuroscience Antibodies And Assays Market by Product
11.1.7.2.2 Canada Neuroscience Antibodies And Assays Market by Technology
11.1.7.2.3 Canada Neuroscience Antibodies And Assays Market by Application
11.1.7.2.4 Canada Neuroscience Antibodies And Assays Market by End User
11.1.7.3 Mexico Neuroscience Antibodies And Assays Market
11.1.7.3.1 Mexico Neuroscience Antibodies And Assays Market by Product
11.1.7.3.2 Mexico Neuroscience Antibodies And Assays Market by Technology
11.1.7.3.3 Mexico Neuroscience Antibodies And Assays Market by Application
11.1.7.3.4 Mexico Neuroscience Antibodies And Assays Market by End User
11.2. EUROPE
11.2.1 Europe Neuroscience Antibodies And Assays Market Overview
11.2.2 Europe Neuroscience Antibodies And Assays Market Forecasts and Analysis
11.2.3 Europe Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Product
11.2.4 Europe Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Technology
11.2.5 Europe Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Application
11.2.6 Europe Neuroscience Antibodies And Assays Market Forecasts and Analysis - By End User
11.2.7 Europe Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Neuroscience Antibodies And Assays Market
11.2.7.1.1 Germany Neuroscience Antibodies And Assays Market by Product
11.2.7.1.2 Germany Neuroscience Antibodies And Assays Market by Technology
11.2.7.1.3 Germany Neuroscience Antibodies And Assays Market by Application
11.2.7.1.4 Germany Neuroscience Antibodies And Assays Market by End User
11.2.7.2 France Neuroscience Antibodies And Assays Market
11.2.7.2.1 France Neuroscience Antibodies And Assays Market by Product
11.2.7.2.2 France Neuroscience Antibodies And Assays Market by Technology
11.2.7.2.3 France Neuroscience Antibodies And Assays Market by Application
11.2.7.2.4 France Neuroscience Antibodies And Assays Market by End User
11.2.7.3 Italy Neuroscience Antibodies And Assays Market
11.2.7.3.1 Italy Neuroscience Antibodies And Assays Market by Product
11.2.7.3.2 Italy Neuroscience Antibodies And Assays Market by Technology
11.2.7.3.3 Italy Neuroscience Antibodies And Assays Market by Application
11.2.7.3.4 Italy Neuroscience Antibodies And Assays Market by End User
11.2.7.4 Spain Neuroscience Antibodies And Assays Market
11.2.7.4.1 Spain Neuroscience Antibodies And Assays Market by Product
11.2.7.4.2 Spain Neuroscience Antibodies And Assays Market by Technology
11.2.7.4.3 Spain Neuroscience Antibodies And Assays Market by Application
11.2.7.4.4 Spain Neuroscience Antibodies And Assays Market by End User
11.2.7.5 United Kingdom Neuroscience Antibodies And Assays Market
11.2.7.5.1 United Kingdom Neuroscience Antibodies And Assays Market by Product
11.2.7.5.2 United Kingdom Neuroscience Antibodies And Assays Market by Technology
11.2.7.5.3 United Kingdom Neuroscience Antibodies And Assays Market by Application
11.2.7.5.4 United Kingdom Neuroscience Antibodies And Assays Market by End User
11.2.7.6 Rest of Europe Neuroscience Antibodies And Assays Market
11.2.7.6.1 Rest of Europe Neuroscience Antibodies And Assays Market by Product
11.2.7.6.2 Rest of Europe Neuroscience Antibodies And Assays Market by Technology
11.2.7.6.3 Rest of Europe Neuroscience Antibodies And Assays Market by Application
11.2.7.6.4 Rest of Europe Neuroscience Antibodies And Assays Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Neuroscience Antibodies And Assays Market Overview
11.3.2 Asia-Pacific Neuroscience Antibodies And Assays Market Forecasts and Analysis
11.3.3 Asia-Pacific Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Neuroscience Antibodies And Assays Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Neuroscience Antibodies And Assays Market
11.3.7.1.1 Australia Neuroscience Antibodies And Assays Market by Product
11.3.7.1.2 Australia Neuroscience Antibodies And Assays Market by Technology
11.3.7.1.3 Australia Neuroscience Antibodies And Assays Market by Application
11.3.7.1.4 Australia Neuroscience Antibodies And Assays Market by End User
11.3.7.2 China Neuroscience Antibodies And Assays Market
11.3.7.2.1 China Neuroscience Antibodies And Assays Market by Product
11.3.7.2.2 China Neuroscience Antibodies And Assays Market by Technology
11.3.7.2.3 China Neuroscience Antibodies And Assays Market by Application
11.3.7.2.4 China Neuroscience Antibodies And Assays Market by End User
11.3.7.3 India Neuroscience Antibodies And Assays Market
11.3.7.3.1 India Neuroscience Antibodies And Assays Market by Product
11.3.7.3.2 India Neuroscience Antibodies And Assays Market by Technology
11.3.7.3.3 India Neuroscience Antibodies And Assays Market by Application
11.3.7.3.4 India Neuroscience Antibodies And Assays Market by End User
11.3.7.4 Japan Neuroscience Antibodies And Assays Market
11.3.7.4.1 Japan Neuroscience Antibodies And Assays Market by Product
11.3.7.4.2 Japan Neuroscience Antibodies And Assays Market by Technology
11.3.7.4.3 Japan Neuroscience Antibodies And Assays Market by Application
11.3.7.4.4 Japan Neuroscience Antibodies And Assays Market by End User
11.3.7.5 South Korea Neuroscience Antibodies And Assays Market
11.3.7.5.1 South Korea Neuroscience Antibodies And Assays Market by Product
11.3.7.5.2 South Korea Neuroscience Antibodies And Assays Market by Technology
11.3.7.5.3 South Korea Neuroscience Antibodies And Assays Market by Application
11.3.7.5.4 South Korea Neuroscience Antibodies And Assays Market by End User
11.3.7.6 Rest of Asia-Pacific Neuroscience Antibodies And Assays Market
11.3.7.6.1 Rest of Asia-Pacific Neuroscience Antibodies And Assays Market by Product
11.3.7.6.2 Rest of Asia-Pacific Neuroscience Antibodies And Assays Market by Technology
11.3.7.6.3 Rest of Asia-Pacific Neuroscience Antibodies And Assays Market by Application
11.3.7.6.4 Rest of Asia-Pacific Neuroscience Antibodies And Assays Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Neuroscience Antibodies And Assays Market Overview
11.4.2 Middle East and Africa Neuroscience Antibodies And Assays Market Forecasts and Analysis
11.4.3 Middle East and Africa Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Neuroscience Antibodies And Assays Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Neuroscience Antibodies And Assays Market
11.4.7.1.1 South Africa Neuroscience Antibodies And Assays Market by Product
11.4.7.1.2 South Africa Neuroscience Antibodies And Assays Market by Technology
11.4.7.1.3 South Africa Neuroscience Antibodies And Assays Market by Application
11.4.7.1.4 South Africa Neuroscience Antibodies And Assays Market by End User
11.4.7.2 Saudi Arabia Neuroscience Antibodies And Assays Market
11.4.7.2.1 Saudi Arabia Neuroscience Antibodies And Assays Market by Product
11.4.7.2.2 Saudi Arabia Neuroscience Antibodies And Assays Market by Technology
11.4.7.2.3 Saudi Arabia Neuroscience Antibodies And Assays Market by Application
11.4.7.2.4 Saudi Arabia Neuroscience Antibodies And Assays Market by End User
11.4.7.3 U.A.E Neuroscience Antibodies And Assays Market
11.4.7.3.1 U.A.E Neuroscience Antibodies And Assays Market by Product
11.4.7.3.2 U.A.E Neuroscience Antibodies And Assays Market by Technology
11.4.7.3.3 U.A.E Neuroscience Antibodies And Assays Market by Application
11.4.7.3.4 U.A.E Neuroscience Antibodies And Assays Market by End User
11.4.7.4 Rest of Middle East and Africa Neuroscience Antibodies And Assays Market
11.4.7.4.1 Rest of Middle East and Africa Neuroscience Antibodies And Assays Market by Product
11.4.7.4.2 Rest of Middle East and Africa Neuroscience Antibodies And Assays Market by Technology
11.4.7.4.3 Rest of Middle East and Africa Neuroscience Antibodies And Assays Market by Application
11.4.7.4.4 Rest of Middle East and Africa Neuroscience Antibodies And Assays Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Neuroscience Antibodies And Assays Market Overview
11.5.2 South and Central America Neuroscience Antibodies And Assays Market Forecasts and Analysis
11.5.3 South and Central America Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Product
11.5.4 South and Central America Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Technology
11.5.5 South and Central America Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Application
11.5.6 South and Central America Neuroscience Antibodies And Assays Market Forecasts and Analysis - By End User
11.5.7 South and Central America Neuroscience Antibodies And Assays Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Neuroscience Antibodies And Assays Market
11.5.7.1.1 Brazil Neuroscience Antibodies And Assays Market by Product
11.5.7.1.2 Brazil Neuroscience Antibodies And Assays Market by Technology
11.5.7.1.3 Brazil Neuroscience Antibodies And Assays Market by Application
11.5.7.1.4 Brazil Neuroscience Antibodies And Assays Market by End User
11.5.7.2 Argentina Neuroscience Antibodies And Assays Market
11.5.7.2.1 Argentina Neuroscience Antibodies And Assays Market by Product
11.5.7.2.2 Argentina Neuroscience Antibodies And Assays Market by Technology
11.5.7.2.3 Argentina Neuroscience Antibodies And Assays Market by Application
11.5.7.2.4 Argentina Neuroscience Antibodies And Assays Market by End User
11.5.7.3 Rest of South and Central America Neuroscience Antibodies And Assays Market
11.5.7.3.1 Rest of South and Central America Neuroscience Antibodies And Assays Market by Product
11.5.7.3.2 Rest of South and Central America Neuroscience Antibodies And Assays Market by Technology
11.5.7.3.3 Rest of South and Central America Neuroscience Antibodies And Assays Market by Application
11.5.7.3.4 Rest of South and Central America Neuroscience Antibodies And Assays Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET, KEY COMPANY PROFILES
14.1. F. HOFFMANN-LA ROCHE LTD.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. THERMO FISHER SCIENTIFIC INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. MERCK KGAA
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. BIO-RAD LABORATORIES, INC.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. SIEMENS
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. GENSCRIPT
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. CELL SIGNALING TECHNOLOGY, INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. SANTA CRUZ BIOTECHNOLOGY, INC.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. BIOLEGEND, INC.
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. ABCAM PLC.
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS

The List of Companies

1. F. Hoffmann-La Roche Ltd.
2. Thermo Fisher Scientific Inc.
3. Merck KGaA
4. Bio-Rad Laboratories, Inc.
5. Siemens
6. GenScript
7. Cell Signaling Technology, Inc.
8. Santa Cruz Biotechnology, Inc.
9. BioLegend, Inc.
10. Abcam plc.

TIPBT00002234
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.